Benzinga | Apr 29, 2021 04:25PM EDT

Pacific Biosciences Q1 EPS $(0.45), Inline, Sales $29.00M Beat $25.67M Estimate

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.45) per share which met the analyst consensus estimate. This is a 4600 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $29.00 million which beat the analyst consensus estimate of $25.67 million by 12.97 percent. This is a 85.92 percent increase over sales of $15.60 million the same period last year.